COVID-19 |

Dr. Methode Bacanamwo

Dr. Methode Bacanamwo

Scientific Review Officer


Division of Basic and Integrative Biological Sciences DBIB
Genes, Genomes and Genetics GGG
Study Section:
Genomics, Computational Biology and Technology GCAT

Dr. Bacanamwo is the Scientific Review Officer for CSR’s Therapeutic Approaches to Genetic Diseases Study Section. He received his Master of Science degree from Clemson University and his doctoral degree in biochemistry from the University of Illinois at Urbana-Champaign. Following post-doctoral trainings at the Universities of Arkansas and Missouri, he joined the faculty at the Morehouse School of Medicine in the Departments of Medicine and Physiology. His NIH-funded research focused on stem cell and cardiovascular epigenetics, especially epigenetic mechanisms mediating drug-resistant hypertension and vascular cell specification. He served on several NIH study sections and SEPs as an ad-hoc reviewer and was a standing member of the Therapeutic Approach to Genetic diseases study section in CSR. He was also a standing member of several review panels for national and international agencies. Before joining CSR, Dr. Bacanamwo was an associate professor at the Morehouse School of Medicine.